Strides Pharma Science Limited (STAR) - Total Assets

Latest as of March 2026: Rs69.27 Billion INR ≈ $749.15 Million USD

Based on the latest financial reports, Strides Pharma Science Limited (STAR) holds total assets worth Rs69.27 Billion INR (≈ $749.15 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore STAR operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.

Strides Pharma Science Limited - Total Assets Trend (2005–2026)

This chart illustrates how Strides Pharma Science Limited's total assets have evolved over time, based on quarterly financial data. See Strides Pharma Science Limited (STAR) net assets for net asset value and shareholders' equity analysis.

Strides Pharma Science Limited - Asset Composition Analysis

Current Asset Composition (March 2026)

Strides Pharma Science Limited's total assets of Rs69.27 Billion consist of 52.2% current assets and 47.9% non-current assets.

Asset Category	Amount (INR)	% of Total Assets
Cash & Equivalents	Rs0.00	3.1%
Accounts Receivable	Rs12.97 Billion	18.7%
Inventory	Rs16.35 Billion	23.6%
Property, Plant & Equipment	Rs0.00	0.0%
Intangible Assets	Rs8.00 Billion	11.5%
Goodwill	Rs5.94 Billion	8.6%

Asset Composition Trend (2005–2026)

This chart illustrates how Strides Pharma Science Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market cap of Strides Pharma Science Limited.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Strides Pharma Science Limited's current assets represent 52.2% of total assets in 2026, an increase from 47.1% in 2005.
Cash Position: Cash and equivalents constituted 3.1% of total assets in 2026, down from 4.4% in 2005.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 19.0% of total assets, an increase from 4.0% in 2005.
Asset Diversification: The largest asset category is inventory at 23.6% of total assets.

Strides Pharma Science Limited Competitors by Total Assets

Key competitors of Strides Pharma Science Limited based on total assets are shown below.

Company	Country	Total Assets
Takeda Pharmaceutical Company Limited F:TKDA	Germany	€15.41 Trillion
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	China	CN¥19.57 Billion
Beijing Sun Novo Pharmaceutical Research Co Ltd SHG:688621	China	CN¥2.30 Billion
Guizhou Xinbang Pharmaceutical Co Ltd SHE:002390	China	CN¥8.59 Billion
Guangdong Lifestrong Pharmacy Co. Ltd. SHE:301111	China	CN¥925.41 Million
Jw Pharmac KO:001060	Korea	₩605.27 Billion
Kamada TA:KMDA	Israel	ILA377.21 Million
Samjin Pharm KO:005500	Korea	₩449.14 Billion

Strides Pharma Science Limited - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	1.25	1.20	1.03
Quick Ratio	0.68	0.70	0.59
Cash Ratio	0.00	0.00	0.00
Working Capital	Rs7.17 Billion	Rs5.07 Billion	Rs814.64 Million

Strides Pharma Science Limited - Advanced Valuation Insights

This section examines the relationship between Strides Pharma Science Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	3.10
Latest Market Cap to Assets Ratio	0.01
Asset Growth Rate (YoY)	14.5%
Total Assets	Rs69.27 Billion
Market Capitalization	$1.03 Billion USD

Valuation Analysis

Below Book Valuation: The market values Strides Pharma Science Limited's assets below their book value (0.01x), which may indicate investor concerns about asset quality or future growth.

Rapid Asset Growth: Strides Pharma Science Limited's assets grew by 14.5% over the past year, indicating significant expansion of the company's resource base.

Annual Total Assets for Strides Pharma Science Limited (2005–2026)

The table below shows the annual total assets of Strides Pharma Science Limited from 2005 to 2026.

Year	Total Assets	Change
2026-03-31	Rs69.27 Billion ≈ $749.15 Million	+14.52%
2025-03-31	Rs60.49 Billion ≈ $654.15 Million	+3.58%
2024-03-31	Rs58.40 Billion ≈ $631.55 Million	-12.03%
2023-03-31	Rs66.38 Billion ≈ $717.92 Million	-4.84%
2022-03-31	Rs69.76 Billion ≈ $754.41 Million	-0.56%
2021-03-31	Rs70.15 Billion ≈ $758.65 Million	+14.03%
2020-03-31	Rs61.52 Billion ≈ $665.29 Million	-23.16%
2019-03-31	Rs80.06 Billion ≈ $865.77 Million	+22.34%
2018-03-31	Rs65.44 Billion ≈ $707.68 Million	-19.38%
2017-03-31	Rs81.17 Billion ≈ $877.80 Million	+5.98%
2016-03-31	Rs76.59 Billion ≈ $828.30 Million	+208.08%
2015-03-31	Rs24.86 Billion ≈ $268.86 Million	+18.44%
2014-03-31	Rs20.99 Billion ≈ $227.00 Million	-56.25%
2013-03-31	Rs47.98 Billion ≈ $518.84 Million	-12.20%
2012-03-31	Rs54.64 Billion ≈ $590.93 Million	+21.61%
2011-03-31	Rs44.93 Billion ≈ $485.94 Million	+39.12%
2010-03-31	Rs32.30 Billion ≈ $349.29 Million	+38.77%
2009-03-31	Rs23.27 Billion ≈ $251.70 Million	+14.46%
2008-03-31	Rs20.33 Billion ≈ $219.91 Million	+65.73%
2007-03-31	Rs12.27 Billion ≈ $132.69 Million	+31.10%
2006-03-31	Rs9.36 Billion ≈ $101.22 Million	+71.20%
2005-03-31	Rs5.47 Billion ≈ $59.12 Million	--

About Strides Pharma Science Limited

NSE:STAR India Drug Manufacturers - Specialty & Generic

Market Cap

$1.03 Billion

Rs94.80 Billion INR

Market Cap Rank

#8703 Global

#438 in India

Share Price

Rs1028.50

Change (1 day)

+0.34%

52-Week Range

Rs793.55 - Rs1188.10

All Time High

Rs1643.30